News

Although cures for age-related macular degeneration are elusive, the case for prevention through nutrition looks strong and ...
NIH scientists explore a new multi-graft retinal surgery technique to advance cell therapy for treating dry age-related ...
Steven T. Reed, O.D., discusses age-related macular degeneration (AMD), the leading cause of severe vision loss in adults ...
LUCIA pivotal Phase 3 trial continues rapid enrollment pace with 60% of patients randomized; enrollment completion expected in 3Q 2025 – – Topline 56-week data for LUGANO expected in mid-2026 with ...
Key trends include advanced multicolor laser adoption and increased outpatient treatments. Challenges include reimbursement issues and competition from alternative therapies. Leading players like ...
A new study from the National Eye Institute has found that eating foods high in dietary nitrates—mainly from vegetables—may ...
Numerous autoimmune diseases are associated with the development of age-related macular degeneration (AMD), according to ...
Lupin has signed an agreement with SteinCares for the commercialization of biosimilar ranibizumab in Latin America, excluding ...
An inexpensive, long-approved HIV drug can improve vision in patients with a blinding complication of diabetes more ...
Inherited retinal degenerations (IRDs) are a group of genetic disorders that lead to progressive vision loss as the ...
Lupin will manufacture biosimilar ranibizumab while SteinCares handles registration and marketing in Latin America, excluding ...